Scholarlink

<p><i>PTEN</i> hamartoma tumour syndrome (PHTS) is a diverse multi-system disorder predisposing to a high hereditary risk of breast, thyroid, endometrial, and&#xa0;a moderate risk of renal, and&#xa0;colorectal cancer and skin melanoma. Besides the risk of cancer, PHTS is also associated with benign tumours such as skin and connective tissue tumours, vascular malformations and neurodevelopmental disorders, including autism spectrum disorders. New evidence on cancer risks and the effectiveness of surveillance has been published since the last iteration of the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS) guidelines from 2020, necessitating the update presented here A comprehensive literature review was undertaken, and guidelines were revised by clinicians with PHTS expertise from relevant medical disciplines, together with PHTS patients and their representatives. Revised recommendations were put forward for surveillance for breast, thyroid, endometrial, renal, and colorectal cancer and skin melanoma. The proposed cancer surveillance recommendations for PHTS require significant patient commitment as well as a coordinated multidisciplinary medical approach. There is a need for prospective evaluation of the effectiveness of these recommendations in the PHTS population.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

ERN GENTURIS cancer surveillance guideline for individuals with PTEN hamartoma tumour syndrome (PHTS)

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月16日

查看全文
  • Nicoline Hoogerbrugge,
  • Ana Blatnik,
  • Charlotte Kvist Lautrup,
  • Robert Hüneburg,
  • Daniela Turchetti,
  • Anne van Altena,
  • Frédéric Caux,
  • Sophie Da Mota Gomes,
  • Kelly Kearley,
  • Chella RS van der Post,
  • Alex Teulé,
  • Jolanda Schieving,
  • Inga-Lena Nilsson,
  • Ritse Mann,
  • Per-Olof Lundgren,
  • Thera Links,
  • Emma Tham,
  • Sjaak Pouwels,
  • Marc Tischkowitz

摘要

PTEN hamartoma tumour syndrome (PHTS) is a diverse multi-system disorder predisposing to a high hereditary risk of breast, thyroid, endometrial, and a moderate risk of renal, and colorectal cancer and skin melanoma. Besides the risk of cancer, PHTS is also associated with benign tumours such as skin and connective tissue tumours, vascular malformations and neurodevelopmental disorders, including autism spectrum disorders. New evidence on cancer risks and the effectiveness of surveillance has been published since the last iteration of the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS) guidelines from 2020, necessitating the update presented here A comprehensive literature review was undertaken, and guidelines were revised by clinicians with PHTS expertise from relevant medical disciplines, together with PHTS patients and their representatives. Revised recommendations were put forward for surveillance for breast, thyroid, endometrial, renal, and colorectal cancer and skin melanoma. The proposed cancer surveillance recommendations for PHTS require significant patient commitment as well as a coordinated multidisciplinary medical approach. There is a need for prospective evaluation of the effectiveness of these recommendations in the PHTS population.